BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29158805)

  • 1. Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53.
    Chen K; Zhang F; Ding J; Liang Y; Zhan Z; Zhan Y; Chen LH; Ding Y
    J Cancer; 2017; 8(16):3318-3330. PubMed ID: 29158805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression.
    Cao N; Yu Y; Zhu H; Chen M; Chen P; Zhuo M; Mao Y; Li L; Zhao Q; Wu M; Ye M
    Cell Death Dis; 2020 May; 11(5):351. PubMed ID: 32393761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
    Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer
    Tian J; Wang W; Zhu J; Zhuang Y; Qi C; Cai Z; Yan W; Lu W; Shang A
    J Immunol Res; 2022; 2022():4012920. PubMed ID: 35497876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.
    Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL
    Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
    Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
    Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis.
    Klonou A; Korkolopoulou P; Giannopoulou AI; Kanakoglou DS; Pampalou A; Gargalionis AN; Sarantis P; Mitsios A; Sgouros S; Papavassiliou AG; Piperi C
    J Mol Med (Berl); 2023 Apr; 101(4):387-401. PubMed ID: 36811655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
    Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
    BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
    Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle.
    She X; Wu Q; Rao Z; Song D; Huang C; Feng S; Liu A; Liu L; Wan K; Li X; Yu C; Qiu C; Luo X; Hu J; Wang G; Xu F; Sun L
    Adv Sci (Weinh); 2023 Oct; 10(28):e2301871. PubMed ID: 37541664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Huang J; Huang W; Liu M; Zhu J; Jiang D; Xiong Y; Zhen Y; Yang D; Chen Z; Peng L; Yu Z
    Oncol Rep; 2018 Aug; 40(2):1017-1025. PubMed ID: 29901162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
    Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
    PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53.
    Fei Q; Shang K; Zhang J; Chuai S; Kong D; Zhou T; Fu S; Liang Y; Li C; Chen Z; Zhao Y; Yu Z; Huang Z; Hu M; Ying H; Chen Z; Zhang Y; Xing F; Zhu J; Xu H; Zhao K; Lu C; Atadja P; Xiao ZX; Li E; Shou J
    Nat Commun; 2015 Oct; 6():8651. PubMed ID: 26471002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of SETDB1 as a therapeutic target.
    Karanth AV; Maniswami RR; Prashanth S; Govindaraj H; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
    Expert Opin Ther Targets; 2017 Mar; 21(3):319-331. PubMed ID: 28076698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
    Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
    J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.
    Xu M; Tu Y; Bi W; Lundberg MZ; Klooster I; Fletcher JA; Ou WB
    Br J Cancer; 2023 Aug; 129(3):531-540. PubMed ID: 37369845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
    Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
    Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response.
    Zhao Z; Feng L; Peng X; Ma T; Tong R; Zhong L
    Front Pharmacol; 2022; 13():1073713. PubMed ID: 36582533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.